By a News Reporter-Staff News Editor at Biotech Week -- Seattle Genetics, Inc. (NASDAQ:SGEN) announced that management will present at the following upcoming investor conferences. The presentations will be webcast live and available for replay from Seattle Genetics' website at www.seattlegenetics.com in the Investors and News section. Leerink Swann Global Healthcare ConferenceThursday, February 13, 11:35 a.m. Eastern Time, New York
Cowen and Company 34th Annual Health Care ConferenceTuesday, March 4, 10:40 a.m. Eastern Time, Boston
About Seattle Genetics Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS® (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, has been approved for two indications in more than 35 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, ASG-22ME and ASG-15ME. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including AbbVie, Agensys (an affiliate of Astellas), Bayer, Genentech, GlaxoSmithKline and Pfizer. More information can be found at www.seattlegenetics.com (see also Pharmaceutical Companies).
Keywords for this news article include: Antibodies, Pharmaceutical Companies, Immunology, Blood Proteins, Immunoglobulins, Seattle Genetics Inc., Biotechnology Companies, Clinical Trials and Studies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC